| Literature DB >> 29941674 |
Yingang Wu1,2,3, Wei Liu2,6, Yuan Zhou1,2, Tristan Hilton3, Zilong Zhao1,2, Wei Liu2,6, Min Wang4,5, Jason Yeon3, Katie Houck3, Perumal Thiagarajan7,8,9, Fangyi Zhang10, Fu-Dong Shi11,12, Xiaoping Wu4, Min Li5,6, Jing-Fei Dong4,12, Jianning Zhang1,2,3.
Abstract
von Willebrand factor (VWF) is an adhesive ligand, and its activity is proteolytically regulated by the metalloprotease ADAMTS-13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat 13). An elevated level of plasma VWF has been widely considered a marker for endothelial cell activation in trauma and inflammation, but its causal role in these pathological conditions remains poorly defined. Using a fluid percussion injury mouse model, we demonstrated that VWF released during acute traumatic brain injury (TBI) was activated and became microvesicle-bound. The VWF-bound microvesicles promoted vascular leakage and systemic coagulation. Recombinant ADAMTS-13 given either before or after TBI reduced the VWF reactivity with minimal influence on VWF secretion. rADAMTS-13 protected the integrity of endothelial cell barriers and prevented TBI-induced coagulopathy by enhancing VWF cleavage without impairing basal hemostasis. Promoting microvesicle clearance by lactadherin had efficacy similar to that of rADAMTS-13. This study uncovers a novel synergistic action between VWF and cellular microvesicles in TBI-induced vascular leakage and coagulopathy and demonstrates protective effects of rADAMTS-13.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29941674 PMCID: PMC6128082 DOI: 10.1182/blood-2018-03-841932
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 25.476